The Department of Vascular Surgery at Cleveland Clinic has earned an international reputation for excellence in patient care, surgical results, and clinical research. We specialize in the diagnosis and management of a wide range of medical disorder that affect the body’s intricate network of arteries, veins and blood vessels. However, our vascular surgery team is also experienced in treating the more rare vascular disorders such as May-Thurner syndrome, Klippel Trenaunay (K-T) syndrome, median arcuate ligament syndrome, vascular issues affecting athletes such as cyclist induced iliac endofibrosis, congenital vascular defects, and many others.
Take this opportunity to learn more about rare vascular conditions, including their diagnosis and treatment options, and have your questions answered by vascular surgeon Daniel Clair, MD.
Daniel Clair, MD, is Chairman of the Department of Vascular Surgery and a Vascular Surgeon practicing at Cleveland Clinic's main campus. Dr. Clair is board-certified in general and vascular surgery. He specializes in carotid artery surgery, thoraco-abdominal aortic repair/reconstruction, thoracic aortic aneurysm repair, abdominal aortic aneurysm repair, peripheral artery/vein repair/bypass surgery, aortic aneurysm stent repair, endovascular stent repair, thoracic outlet syndrome and chronic venous occlusive disease.
Dr. Clair received his medical degree from the University of Virginia School of Medicine in Charlottesville, Va., where he was inducted into the medical honor society Alpha Omega Alpha. He took his internship and residency in surgery at Brigham and Women’s Hospital in Boston, becoming Chief Resident in Surgery and receiving the F.D. Moore Resident Teaching Award. Dr. Clair completed his training with clinical and research fellowships, among them a fellowship in clinical oncology from the American Cancer Society; a fellowship in vascular surgery from Brigham and Women’s Hospital in Boston, where he became an associate surgeon; and research fellowship as Research Scientist at VazoRx, Inc., in Woburn, Mass.
For four years, Dr. Clair was an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Md., completing his military service stationed at Andrews AFB, Md., as Chief of the Vascular Surgery Section. He has had a number of academic appointments including Clinical Fellow in Surgery at Harvard Medical School, where he was also Instructor in Surgery. He also taught at Columbia University College of Physicians and Surgeons as Assistant Professor of Surgery, where he served as the Chief of the Vascular Surgery Service, and at Weill Medical College of Cornell University, where he was Adjunct Assistant Professor of Surgery. Dr. Clair was appointed to the Cleveland Clinic as a vascular surgeon from 1998 to 2002. He returned to Cleveland Clinic in 2004, and was named Chairman/Program Director of the Department of Vascular Surgery in 2006.
Dr. Clair’s research interests have focused on clinical trials of minimally invasive vascular therapies. He has played a significant role in industry-sponsored clinical trials, most recently as the National Principal Investigator for the EMPIRE Trial in which researchers study a flow reversal system for carotid stenting. He is a Principal Investigator for the ORION trial assessing the performance of a new expandable stent used to treat iliac artery occlusive disease. He has been invited to present his research findings and clinical experience at more than 90 international and national medical conferences and symposia.